Details Of Published TSH Receptor Mutation

Pro 449 Leu

c.1346C>U

Inactivating TSH Receptor Mutation

Type
loss
Manifestation
family
Exon
10
Labadi et al.
Legend:
Male
Female
Unknown
Deceased
+
Mutation
-
Wild-Type
Heterozygous
Heterozygous
Compound Heterozygous
Homozygous
Hypothyroid
Hypoplastic Gland + Hypothyroid
P
Index Patient
Molecular Characteristics:
co-occuring with P162A 
Clinical Features:
congenital hypothyroidism 
Treatment:
default
Functional Characteristics:
cAMP
(basal)
cAMP
(TSH)
IP
(basal)
IP
(TSH)
TSH-Binding
Cell Surface Expression
Prevalence
LRA
Ref
0.805 +/-0
0.611 +/-0
nd
0.169 +/-0
nd
1.191
1
nd
Legend:
cAMP (basal): basal in vitro cAMP production of mutant over wild-type TSHR
cAMP (TSH): maximal in vitro cAMP production of mutant over wild-type TSHR
IP (basal): basal in vitro IP production of mutant over wild-type TSHR
IP (TSH): maximal in vitro IP production of mutant over wild-type TSHR
TSH-binding: maximal TSH-binding compared to the wild-type TSHR
Cell surface expression: cell surface expression of mutant compared to WT-TSHR
LRA: linear regression analysis (LRA) of constitutive activity as a function of TSHR expression determined by 125I-bTSH binding or FACS analysis compared to the wild-type TSHR
Prevalence: Prevalence of (somatic and germline) activating mutations*
Ref: Reference for functional characterization
Child: Found in children.
Reference 1:
Lábadi, Árpád, et al.
The Journal of Clinical Endocrinology & Metabolism
Loss-of-function variants in a Hungarian cohort reveal structural insights on TSH receptor maturation and signaling
2015